FDA commissioner Rob Califf (AP Photo/Jose Luis Magana)
Super-speedy cancer drug reviews: FDA unveils new draft guidance to help sponsors apply
How does a cancer drug cross the FDA finish line 3-5 months before its PDUFA date? That’s where the Real-Time Oncology Review comes in. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
